https://www.sciencedaily.com/releases/2018/10/181011112424.htm
A study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.
https://www.sciencedaily.com/releases/2018/10/181011112424.htm
A study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.